Your test, explained
5 min readTestosterone Bioavailable with SHBG Blood Test: The Ultimate Androgen Profile
A comprehensive quantitative measurement of Total Testosterone and SHBG, utilized to calculate Bioavailable Testosterone. It is the clinical gold standard for accurately diagnosing hypogonadism, hyperandrogenism (PCOS), and optimizing hormone replacement therapy.
Your options, side by side
Compare retailer prices.
Find a listing that fits your needs. Review the details, then order with the retailer.
No retailer listings yet.
Read the test guide or explore other tests in the directory.
Explore testsPrices shown are listed test prices, not checkout totals. Expand a listing for supplied fees and its observation date. Check included measurements, collection requirements, and the performing lab before ordering.
Understand before you decide
The test, explained.
Overview
Relying solely on a Total Testosterone test is a common clinical pitfall. To truly understand your androgenic health, we must differentiate between the hormone that is biologically locked away and the hormone your body can actually use.
As a senior clinical endocrinologist, I utilize the Bioavailable Testosterone with SHBG panel as the definitive diagnostic standard. While Total Testosterone represents the absolute volume of hormone in your bloodstream, up to 70% of it is tightly bound to Sex Hormone Binding Globulin (SHBG) and is completely biologically inert. It cannot enter your cells. The remaining fraction—comprising Free Testosterone and testosterone loosely bound to albumin—makes up your Bioavailable Testosterone. By meticulously measuring Total T and SHBG, and mathematically deriving the bioavailable fraction, this test cuts through the biochemical noise. It reveals your true functional hormone status, reducing clinical misdiagnosis of hypogonadism by up to 15%.
About this test
Advanced Clinical Diagnostic Utility of Bioavailable Testosterone
To extract genuine clinical utility from this endocrine panel, it must be viewed as a dynamic assessment of hormone transport and tissue-level availability.
1. The SHBG Sinkhole
The Illusion of Normalcy: A patient may present with profound symptoms of androgen deficiency (chronic fatigue, erectile dysfunction, muscle wasting) yet have a 'normal' Total Testosterone level. If their liver is overproducing SHBG—a common occurrence with aging, hyperthyroidism, or certain liver pathologies—that SHBG acts as a sinkhole, tightly binding the testosterone. Measuring the Bioavailable fraction immediately reveals that their tissues are actually starving for active hormones.
2. Bioavailable vs. Free Testosterone
The Albumin Advantage: While Free Testosterone (completely unbound) is highly active, it only represents 1-2% of total hormones. Testosterone bound to albumin (a highly abundant blood protein) is bound so loosely that it readily dissociates at the capillary bed, entering the tissue. Bioavailable Testosterone includes BOTH the Free and Albumin-bound fractions, representing the true, total amount of testosterone your body can actively deploy.
3. Female Hyperandrogenism and Metabolic Syndrome
The PCOS Biosensor: In females, hyperinsulinemia (insulin resistance) directly suppresses hepatic SHBG production. As SHBG falls, Bioavailable Testosterone skyrockets, directly driving the masculinizing symptoms of Polycystic Ovary Syndrome (PCOS), such as cystic acne, hirsutism, and anovulation. This test precisely phenotypes the metabolic and hormonal drivers of female infertility.
When to discuss this test
You should prioritize this targeted endocrine evaluation when:
- Men: You exhibit the classic triad of hypogonadism (loss of morning erections, fatigue, low libido) but your primary care physician previously dismissed you because your 'Total Testosterone' was within the normal reference range.
- Women: You are experiencing unexplained facial hair growth, severe jawline acne, temporal balding, or irregular menstrual cycles suggestive of androgen excess or PCOS.
- Therapy Optimization: You are currently on Testosterone Replacement Therapy (TRT) and need to ensure your dosing protocol is yielding adequate tissue-level hormone, rather than simply driving up SHBG and Total T.
- Metabolic Tracking: You have been diagnosed with obesity, insulin resistance, or fatty liver disease, all of which aggressively distort the SHBG-to-Testosterone ratio.
Who may benefit
This test is an absolute necessity for functional endocrinologists managing aging populations, urologists distinguishing between primary and secondary hypogonadism, gynecologists investigating the metabolic roots of PCOS, and sports medicine physicians tracking androgen recovery in overtrained athletes.
How this test is used
- Hidden / Normotestosteronemic Hypogonadism (Male)
- Polycystic Ovary Syndrome (PCOS) & Hyperandrogenism (Female)
- Sex Hormone-Binding Globulin (SHBG) Abnormalities
- Altered Androgen Bioavailability due to Hepatic/Metabolic Disease
Before your appointment
Plan your visit.
- Fasting
- Required · 10 hours
- Collection timing
- Morning collection preferred
How to prepare
- Strict Fasting (10-12 Hours): As a metabolic and endocrine specialist, I mandate an overnight fast of 10-12 hours for this assay. Consuming a meal, particularly one rich in carbohydrates, triggers an acute insulin release. Insulin strongly suppresses hepatic SHBG synthesis and can acutely drop circulating testosterone by 15-25% for several hours. A strict fasting baseline ensures absolute diagnostic accuracy. Water is permitted and encouraged.
- Morning Collection (6:00 AM - 10:00 AM): Testosterone secretion is highly pulsatile and follows a strict circadian rhythm, peaking during the later stages of REM sleep. Blood drawn after 10:00 AM will reflect a natural diurnal decline, rendering it clinically invalid for diagnosing hypogonadism.
- Medication and Supplement Disclosure: Inform your provider of any corticosteroids, anticonvulsants, or oral estrogens, as these drastically alter SHBG levels. You must also discontinue high-dose Biotin (Vitamin B7) supplements at least 72 hours prior to the draw, as biotin causes severe interference with the immunoassay platforms used for SHBG and Testosterone.
Important considerations
The Reference Range Trap: Because SHBG naturally rises with age, older men will inherently have a lower percentage of Bioavailable Testosterone compared to younger men with the exact same Total Testosterone level. Always rely on the calculated Bioavailable fraction to determine clinical deficiency, rather than age-adjusted Total Testosterone reference ranges, which often mask severe functional deficiencies in the elderly.
Follow the instructions from your retailer and clinician. Information on this page is educational and does not replace individual medical advice.
See what to expect
Sample reports & resources.
Published examples and supporting files for this test.
No sample files are published for this test yet.
Looking for your own results? Open your reports dashboard
For a closer look
Sources & further reading.
Further reading
Recent Clinical Breakthroughs (2024-2025):
- Bioavailable T and Cardiovascular Mortality: A landmark 2024 study published in the Journal of the American College of Cardiology demonstrated that low Bioavailable Testosterone, but not Total Testosterone, is a primary independent predictor of major adverse cardiovascular events (MACE) in men over 50. The study established that active tissue androgens are required to maintain endothelial nitric oxide synthesis and vascular compliance.
- Re-evaluating Hypogonadism Criteria: Revised 2025 guidelines from the Endocrine Society now strongly recommend utilizing Bioavailable Testosterone (calculated via SHBG) as the primary confirmatory diagnostic tool for adult-onset hypogonadism. Clinical data showed that relying on Total Testosterone alone resulted in a 15% misdiagnosis rate, leaving millions of symptomatic men untreated due to artificially elevated SHBG masking their deficiency.
- PCOS Insulin-Androgen Dynamics: Breakthrough 2025 gynecological research revealed that in women with PCOS, the ratio of Bioavailable Testosterone to fasting insulin is the single most accurate predictor of anovulatory infertility, prompting a shift away from isolated Total Testosterone testing in functional fertility clinics.
Sources
- Journal of the American College of Cardiology (2024). "Bioavailable Testosterone as an Independent Predictor of Endothelial Dysfunction and Cardiovascular Mortality in Aging Men."
- Journal of Clinical Endocrinology & Metabolism (Endocrine Society, 2025). "Updating Diagnostic Thresholds: The Mandate for Bioavailable Testosterone and SHBG in Adult-Onset Hypogonadism."
- Fertility and Sterility (2025). "The Bioavailable Androgen-Insulin Index: Redefining Predictive Biomarkers for Anovulation in Polycystic Ovary Syndrome."